Summary & Overview
HCPCS G9584: Opioid Misuse Risk Assessment
HCPCS Level II code G9584 documents a brief validated assessment or interview to evaluate a patient’s risk of opioid misuse during opioid therapy. Nationally, routine risk assessment for opioid prescribing has become a core component of safer opioid management and quality programs across payers and health systems. Use of G9584 facilitates standardized capture of risk-screening activities that inform prescribers, care teams, and payers about patient-level risk and monitoring needs.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical intent and settings, typical use cases, and what this code represents in payer coverage contexts. The analysis highlights common benchmarks for documentation of opioid risk screening, implications for quality measurement, and how G9584 aligns with broader efforts to track risk assessment in outpatient care.
This summary provides clinicians, billing staff, and policy analysts a concise national-level view of the code’s purpose, where it is typically used, and the kinds of administrative and clinical conversations that surround its use. Data not available in the input is noted where specific benchmark or payer policy details would normally appear.
Billing Code Overview
HCPCS Level II code G9584 describes an evaluation of a patient for risk of opioid misuse using a brief validated instrument (for example, the opioid risk tool or SOAPP-R) or a documented patient interview at least once during opioid therapy. The service is a risk assessment for opioid misuse intended to identify behavioral, historical, or clinical factors that may increase the likelihood of opioid-related harm.
Service Type: Behavioral/Medication Risk Assessment
Typical Site of Service: Outpatient clinic or ambulatory care setting, including primary care, pain management, or behavioral health visits where opioid therapy is initiated or continued.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with chronic low back pain established in a primary care clinic is maintained on long-acting oxycodone. During a scheduled opioid follow-up visit, the clinician administers a brief validated opioid risk assessment instrument (for example, the Opioid Risk Tool or SOAPP-R) and reviews prior prescription monitoring program (PMP) data and urine drug screen results. The clinician documents the patient’s risk score, discusses risk mitigation strategies, and records that the patient was interviewed at least once during opioid therapy about signs of misuse, adherence, and safe storage.
This service is typically delivered as a focused evaluation during an outpatient clinic visit, substance-use treatment program visit, or medication management appointment. Typical workflow steps include patient self-report or clinician-administered questionnaire, scoring the instrument, integrating results into the medical record, and counseling or care-plan updates as indicated. The service may be provided by primary care physicians, pain medicine specialists, addiction medicine clinicians, nurse practitioners, or physician assistants in office-based settings and outpatient behavioral health clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the opioid-risk assessment required substantially greater work or time than usual and documentation supports the increased complexity. |